Cancer Research urges MPs to back tobacco and vapes bill, saying damage caused by cigarettes cannot be ignored…reports Asian Lite News
MPs are being urged to back plans to make the UK the first country to eradicate smoking, as new figures suggest tobacco will result in almost 300,000 Britons getting cancer within the next five years.
The tobacco and vapes bill, which would prevent anyone born after 1 January 2009 from legally smoking by gradually raising the age at which tobacco can be bought, will have its second reading in the House of Commons on Tuesday.
Cancer Research UK said the “magnitude of damage” caused by cigarettes and tobacco – the leading cause of death in the UK – could no longer be ignored by MPs, especially as 350 young people take up smoking every day.
It said the bill was a “historic opportunity” to prevent thousands of cancers and significantly reduce pressure on the overstretched NHS.
Analysis published by the charity on Monday estimates there could be 296,661 new cases of cancer across the UK by 2029 if current trends continue. It found that on average last year nearly 160 cancer cases attributed to smoking were diagnosed every day.
The study projects cases of cancer caused by smoking before the end of this parliamentary term, which researchers assumed to be in July 2029. It estimated 243,045 cases in England, 29,365 in Scotland, 15,161 in Wales and 9,090 in Northern Ireland.
Overall, 2,846 cancer cases in the UK could be caused by exposure to secondhand smoke in people who have never smoked themselves, the analysis found. The latest Office for National Statistics annual population survey estimates about 11.9% of people aged 18 or over – the equivalent of about 6 million people – smoked cigarettes in the UK in 2023. It is the lowest proportion of current smokers since ONS records began in 2011.
However, research shows the equivalent of about 350 adults aged 18 to 25 start smoking every day, with 35,000 having taken up the habit since the king’s speech in July, Cancer Research said. Dr Ian Walker, the charity’s executive director of policy, said: “Tobacco kills up to two-thirds of its users. The magnitude of damage caused by smoking cannot be ignored and these statistics expose the lives that are at stake. We know that smoking rates decline with government intervention. Raising the age of sale of tobacco products and funding cessation services will help to protect people from a lifetime of deadly and costly addiction.”
The charity is urging all MPs to vote in favour of the tobacco and vapes bill. The bill was introduced in parliament at the beginning of November. It could prevent anyone born after 1 January 2009 from legally smoking by gradually raising the age at which tobacco can be bought.
Restrictions on vape advertising and sponsorship could also be introduced as well as restrictions on flavours, displays and packaging to reduce their appeal to children and young people. Vaping and smoking in playgrounds and outside schools could also be banned.
Walker added: “The tobacco and vapes bill could be one of the most impactful public health interventions in my lifetime. People’s lives are now in the hands of politicians and I urge all MPs to vote for a future free from the harms of tobacco.”
Prof Chris Whitty, the chief medical officer for England, has said the UK finally becoming “smoke-free” would lead to fewer stillbirths and cases of asthma in children, as well as reductions in cancer, strokes, heart disease and dementia.
Meanwhile, hundreds of thousands of smokers will be given a pill that increases people’s chances of quitting, in a move that NHS bosses believe will save thousands of lives.
About 85,000 people a year in England will be offered the chance to use varenicline, a once-a-day tablet that experts say is as effective as vapes at helping people to kick the habit.
Amanda Pritchard, the chief executive of NHS England, hailed the pill as a potential “gamechanger” in the fight to tackle smoking and the huge harm to health it causes.
The drug helps people to quit by reducing their cravings for nicotine and ensuring that it cannot affect the brain in its usual way. It has also been found to reduce the side-effects smokers can experience when they stop using tobacco, such as trouble sleeping and irritability.
The NHS in England will give varenicline as part of its efforts to keep driving down the number of people who smoke. A decline in smoking rates over the past 20 years means that only 11.6% of adults in England still have the habit – about 6 million people.
Health service bosses hope its use will lead to 9,500 fewer smoking-related deaths over the next five years. The drug – known at the time as Champix – began being used in 2006 and was taken by about 85,800 people a year until July 2021. It then became unavailable after the Medicines and Healthcare products Regulatory Agency (MHRA), which regulates drugs, found impurities in it.
That problem has now been addressed to the MHRA’s satisfaction and it has recently approved a generic version of the drug, which NHS England will use. It cited research by University College London that found it would save £1.65 in healthcare costs for every £1 it spent on the pill. The pharmaceutical firm Teva UK will provide the generic version of the drug.
Smoking experts welcomed varenicline’s return. Dr Nicola Lindson, an associate professor at Oxford university, said: “[It] is one of the most effective ways to quit smoking, especially when combined with behavioural support, such as counselling.”
Hazel Cheeseman, the chief executive of Action on Smoking and Health, welcomed the move but said the NHS also needed to improve the help it gives to smokers to quit.
ALSO READ: UK Energy Price Cap To Increase By 1.2%
